Kirti Naranje
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kirti Naranje has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Anita Singh
Neonatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
19 shared publications Akanksha Verma
Department of Neonatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
6 shared publicationsAnita Singh
Department of Neonatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
5 shared publicationsGirish Gupta
Department of Pediatrics, Graphic Era Institute of Medical Sciences, Dehradun, Uttarakhand, India
5 shared publicationsAbhijeet Roy
Department of Neonatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
4 shared publicationsAbhishek Paul
Department of Neonatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
4 shared publications
Latest Publications
- 23 October 2026
- Published by Elsevier in Resuscitation
- Vol. 229, 111365
Comparison of delivery room wrist versus earlobe pulse oximetry in newborns: A randomized controlled trial
- 23 October 2026
- Published by Elsevier in Resuscitation
- Vol. 229, 111365
Comparison of delivery room wrist versus earlobe pulse oximetry in newborns: A randomized controlled trial
- 5 February 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (2) , e268705
Bleeding from umbilicus in a neonate: exploring aetiologies of a common presentation
Bleeding from the umbilical stump is a common clinical presentation with varying aetiologies. A mild amount of bleeding often occurs at the time of cord separation. It is often benign; however, sometimes it may be due to an underlying congenital coagulation disorder, especially when in large amounts. Afibrinogenaemia is an uncommon bleeding disorder characterised by the complete absence or severe deficiency of fibrinogen, a vital protein crucial for the regulation of blood clotting. Its estimated prevalence is around 1 in 1 million newborns and is inherited in an autosomal recessive manner. We report a neonate who was diagnosed with congenital afibrinogenaemia and presented with significant bleeding from the umbilicus. The baby is well managed with fibrinogen replacement therapy. Timely identification and intervention proved pivotal in averting potentially life-threatening bleeding incidents in this neonate.
- 5 February 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (2) , e268705
Bleeding from umbilicus in a neonate: exploring aetiologies of a common presentation
Bleeding from the umbilical stump is a common clinical presentation with varying aetiologies. A mild amount of bleeding often occurs at the time of cord separation. It is often benign; however, sometimes it may be due to an underlying congenital coagulation disorder, especially when in large amounts. Afibrinogenaemia is an uncommon bleeding disorder characterised by the complete absence or severe deficiency of fibrinogen, a vital protein crucial for the regulation of blood clotting. Its estimated prevalence is around 1 in 1 million newborns and is inherited in an autosomal recessive manner. We report a neonate who was diagnosed with congenital afibrinogenaemia and presented with significant bleeding from the umbilicus. The baby is well managed with fibrinogen replacement therapy. Timely identification and intervention proved pivotal in averting potentially life-threatening bleeding incidents in this neonate.
- 31 December 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (12) , e269500
Tachyarrhythmia-induced cardiomyopathy in a neonate
Tachycardia-induced cardiomyopathy (TIC) can result in both systolic and/or diastolic ventricular dysfunction as a result of the prolonged fast heart rate which is reversible on controlling the fast heart rate or arrhythmia. The exact heart rate that can lead to this is not clear; however, a heart rate >180, in general, needs attention in neonates and infants. TIC is a well-established cause of left ventricular dysfunction which usually happens due to an increased atrial or ventricular rate. The incidence of TIC is very low, although the exact incidence is unclear. It should be considered in all patients with dilated cardiomyopathy or those with no obvious explanation for dilated cardiomyopathy, and in the presence of tachycardia or atrial fibrillation with a rapid ventricular response. TIC has also been labelled as arrhythmia-induced cardiomyopathy lately. We present a male term neonate who presented early in the neonatal period with tachyarrhythmia and heart failure and was referred in view of fetal tachycardia and large atrial septal defect-associated atrial dilatation. The baby required synchronised cardioversion along with non-invasive respiratory support, adenosine and esmolol infusions. TIC responded to oral supplementation of furosemide and enalapril at discharge. The baby had improved cardiac function with normal-sized cardiac chambers in follow-up.
- 31 December 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (12) , e269500
Tachyarrhythmia-induced cardiomyopathy in a neonate
Tachycardia-induced cardiomyopathy (TIC) can result in both systolic and/or diastolic ventricular dysfunction as a result of the prolonged fast heart rate which is reversible on controlling the fast heart rate or arrhythmia. The exact heart rate that can lead to this is not clear; however, a heart rate >180, in general, needs attention in neonates and infants. TIC is a well-established cause of left ventricular dysfunction which usually happens due to an increased atrial or ventricular rate. The incidence of TIC is very low, although the exact incidence is unclear. It should be considered in all patients with dilated cardiomyopathy or those with no obvious explanation for dilated cardiomyopathy, and in the presence of tachycardia or atrial fibrillation with a rapid ventricular response. TIC has also been labelled as arrhythmia-induced cardiomyopathy lately. We present a male term neonate who presented early in the neonatal period with tachyarrhythmia and heart failure and was referred in view of fetal tachycardia and large atrial septal defect-associated atrial dilatation. The baby required synchronised cardioversion along with non-invasive respiratory support, adenosine and esmolol infusions. TIC responded to oral supplementation of furosemide and enalapril at discharge. The baby had improved cardiac function with normal-sized cardiac chambers in follow-up.
- 4 November 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (11) , e268902
Congenital disorder of glycosylation type IIb in an infant with developmental and epileptic encephalopathy
We report a term infant presenting in early infancy with progressive developmental delay, feeding difficulties, recurrent seizures and failure to thrive. The infant initially exhibited symptoms from early neonatal age, including vomiting, lethargy and seizures, necessitating multiple hospitalisations. Progressive neurological deterioration, hepatomegaly, bilateral nephromegaly, hypothyroidism, gastro-oesophageal reflux disease and auditory neuropathy were noted. MRI showed cerebral atrophy and dilated ventricles. Extensive investigations ruled out infections, metabolic acidosis and structural brain malformations. Whole exome sequencing identified a homozygous missense mutation in the mannosyl-oligosaccharide glucosidase ( MOGS ) gene (c.2090T>C; p.Leu697Ser), previously reported in MOGS CDG (congenital disorder of glycosylation type IIb). A mannose-based diet led to partial improvement. This case highlights the importance of considering neurometabolic conditions such as CDG in infants with early-onset developmental and epileptic encephalopathy and multisystem involvement. Early diagnosis and supportive multidisciplinary care are vital for improving outcomes and guiding family counselling.
- 4 November 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (11) , e268902
Congenital disorder of glycosylation type IIb in an infant with developmental and epileptic encephalopathy
We report a term infant presenting in early infancy with progressive developmental delay, feeding difficulties, recurrent seizures and failure to thrive. The infant initially exhibited symptoms from early neonatal age, including vomiting, lethargy and seizures, necessitating multiple hospitalisations. Progressive neurological deterioration, hepatomegaly, bilateral nephromegaly, hypothyroidism, gastro-oesophageal reflux disease and auditory neuropathy were noted. MRI showed cerebral atrophy and dilated ventricles. Extensive investigations ruled out infections, metabolic acidosis and structural brain malformations. Whole exome sequencing identified a homozygous missense mutation in the mannosyl-oligosaccharide glucosidase ( MOGS ) gene (c.2090T>C; p.Leu697Ser), previously reported in MOGS CDG (congenital disorder of glycosylation type IIb). A mannose-based diet led to partial improvement. This case highlights the importance of considering neurometabolic conditions such as CDG in infants with early-onset developmental and epileptic encephalopathy and multisystem involvement. Early diagnosis and supportive multidisciplinary care are vital for improving outcomes and guiding family counselling.
- 20 October 2025
- Published by SAGE Publications in Journal of Neonatology
- Vol. 40 (2) , 124-129
Facial Palsy in Neonate: A Cohort Study on Risk Factors and Recovery Patterns
Introduction: Neonatal facial palsy is uncommon. Developmental forms are often bilateral and syndromic, while congenital palsy is usually unilateral and results from birth trauma, compression, iatrogenic injury, or infection. Objectives: To describe about the cases of facial palsy in terms of age of onset, etiology, investigations, recovery, and outcome. Methods: This prospective cohort study over 4 years included neonates with facial palsy. Clinical details, risk factors, and outcomes were documented. All underwent neuroimaging, hearing tests, and ear and eye exams. Eye patching was done, and lubricants were applied. The babies were followed up for 6 months. Results: The total number of observed facial palsy cases was 24 over a period of 4 years. The median birth weight and gestational age were 2,149 g and 34 5/7 weeks, respectively. Approximately 80% of the babies had a history of prior continuous positive airway pressure (CPAP) use. The proportion of recovered cases was significantly more in babies with normal neurological examination ( P = .01) and neuroimaging ( P = .04). Conclusions: Congenital neonatal facial palsy may present at any time shortly after birth or a few days later. With declining forceps use, common causes now include positive end-expiratory pressure (PEEP) devices, intrauterine procedures, central nervous system (CNS) or auditory infections, and perinatal asphyxia. Most cases resolve within a few months.
- 20 October 2025
- Published by SAGE Publications in Journal of Neonatology
- Vol. 40 (2) , 124-129
Facial Palsy in Neonate: A Cohort Study on Risk Factors and Recovery Patterns
Introduction: Neonatal facial palsy is uncommon. Developmental forms are often bilateral and syndromic, while congenital palsy is usually unilateral and results from birth trauma, compression, iatrogenic injury, or infection. Objectives: To describe about the cases of facial palsy in terms of age of onset, etiology, investigations, recovery, and outcome. Methods: This prospective cohort study over 4 years included neonates with facial palsy. Clinical details, risk factors, and outcomes were documented. All underwent neuroimaging, hearing tests, and ear and eye exams. Eye patching was done, and lubricants were applied. The babies were followed up for 6 months. Results: The total number of observed facial palsy cases was 24 over a period of 4 years. The median birth weight and gestational age were 2,149 g and 34 5/7 weeks, respectively. Approximately 80% of the babies had a history of prior continuous positive airway pressure (CPAP) use. The proportion of recovered cases was significantly more in babies with normal neurological examination ( P = .01) and neuroimaging ( P = .04). Conclusions: Congenital neonatal facial palsy may present at any time shortly after birth or a few days later. With declining forceps use, common causes now include positive end-expiratory pressure (PEEP) devices, intrauterine procedures, central nervous system (CNS) or auditory infections, and perinatal asphyxia. Most cases resolve within a few months.
- 25 September 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (9) , e266133
Heartbeat of hope: newborn’s journey with a pacemaker
Congenital heart block is a rare disorder of neonates. It is generally diagnosed in the antenatal period or at birth and is commonly associated with transplacental passage of anti-Ro and/or anti-La antibodies to the fetus. It has a high mortality rate if left untreated. A pacemaker is considered as the treatment of choice, but the expertise for pacemaker implantation is available at only a few centres in India. We present a case of a late preterm neonate with antenatally diagnosed heart block due to anti-Ro antibody in the mother. The baby required delivery room resuscitation and mechanical ventilation. Postnatal ECG was also suggestive of third degree heart block and the baby landed into shock soon after birth. The baby was managed initially with ionotropic agents and an epicardial pacemaker was implanted within 6 hours of life. The baby was discharged successfully with stable vitals.
- 25 September 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (9) , e266133
Heartbeat of hope: newborn’s journey with a pacemaker
Congenital heart block is a rare disorder of neonates. It is generally diagnosed in the antenatal period or at birth and is commonly associated with transplacental passage of anti-Ro and/or anti-La antibodies to the fetus. It has a high mortality rate if left untreated. A pacemaker is considered as the treatment of choice, but the expertise for pacemaker implantation is available at only a few centres in India. We present a case of a late preterm neonate with antenatally diagnosed heart block due to anti-Ro antibody in the mother. The baby required delivery room resuscitation and mechanical ventilation. Postnatal ECG was also suggestive of third degree heart block and the baby landed into shock soon after birth. The baby was managed initially with ionotropic agents and an epicardial pacemaker was implanted within 6 hours of life. The baby was discharged successfully with stable vitals.
- 27 August 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (8) , e267344
Recalcitrant hypocalcaemia responding to teriparatide therapy: a clinical insight
Hypocalcaemia is a common metabolic abnormality in neonates, with distinct causes based on the timing of onset. Early-onset hypocalcaemia (within 72 hours of life) is typically related to transitional physiology, prematurity, perinatal asphyxia or maternal diabetes. In contrast, late-onset hypocalcaemia (after 72 hours) is less common and may result from high phosphate intake, cow’s milk-based formulas, vitamin D deficiency or resistance, maternal vitamin D deficiency, hypoparathyroidism (eg, DiGeorge syndrome), magnesium deficiency or activating mutations in the calcium-sensing receptor. Clinical manifestations of late-onset hypocalcaemia can include seizures, tetany, irritability, arrhythmias or stridor. While most cases respond to oral calcium, vitamin D and magnesium supplementation, some are refractory to conventional therapy. We report a case of refractory neonatal hypocalcaemia that showed significant improvement with teriparatide, a recombinant parathyroid hormone analogue, highlighting the potential role of advanced pharmacological agents in difficult-to-treat cases of neonatal hypocalcaemia.
- 27 August 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (8) , e267344
Recalcitrant hypocalcaemia responding to teriparatide therapy: a clinical insight
Hypocalcaemia is a common metabolic abnormality in neonates, with distinct causes based on the timing of onset. Early-onset hypocalcaemia (within 72 hours of life) is typically related to transitional physiology, prematurity, perinatal asphyxia or maternal diabetes. In contrast, late-onset hypocalcaemia (after 72 hours) is less common and may result from high phosphate intake, cow’s milk-based formulas, vitamin D deficiency or resistance, maternal vitamin D deficiency, hypoparathyroidism (eg, DiGeorge syndrome), magnesium deficiency or activating mutations in the calcium-sensing receptor. Clinical manifestations of late-onset hypocalcaemia can include seizures, tetany, irritability, arrhythmias or stridor. While most cases respond to oral calcium, vitamin D and magnesium supplementation, some are refractory to conventional therapy. We report a case of refractory neonatal hypocalcaemia that showed significant improvement with teriparatide, a recombinant parathyroid hormone analogue, highlighting the potential role of advanced pharmacological agents in difficult-to-treat cases of neonatal hypocalcaemia.
- 12 May 2025
- Published by Elsevier in Early Human Development
- Vol. 207, 106284
Nasal DUOPAP vs nasal continuous positive airway pressure in preterm neonates with respiratory distress syndrome - A randomized control trial
- 12 May 2025
- Published by Elsevier in Early Human Development
- Vol. 207, 106284
Nasal DUOPAP vs nasal continuous positive airway pressure in preterm neonates with respiratory distress syndrome - A randomized control trial
- 5 February 2025
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 71 (2)
Colistin-resistant Klebsiella pneumoniae sepsis in neonates and infants: an alarming crisis in an Indian NICU
Emergence of multidrug-resistant strain of Klebsiella pneumoniae has led to limited number of antimicrobial options for treatment. Even though outbreaks of colistin–carbapenem-resistant K. pneumoniae (CCRKp) are evolving, reported literature is scarce. This is a retrospective case series of three infants who acquired CCRKp sepsis during an outbreak in a Level III neonatal intensive care unit (NICU) of a tertiary care centre in Northern India. Data were retrieved from medical records of patients. Three babies developed new onset clinical worsening during an outbreak of sepsis. All had respiratory comorbidities and previous antibiotic exposure prior to isolation of CCRKp sepsis from blood. The organism was sensitive to combination of ceftazidime plus avibactam and tetracyclines in two infants; in one other newborn, no sensitive antibiotic was found. Two neonates deceased due to multiorgan dysfunction. An outbreak investigation revealed one common source of sterile water used in a humidifier. The outbreak was resolved by temporarily closing the NICU, segregating the infected infants and using corrective measures such as procuring a fresh batch of sterile water bottles, disinfecting the NICU, and reinforcing the use of antiseptic techniques. The emergence of CCRKp is alarming, particularly in low- and middle-income countries and tropical regions where such outbreaks are difficult to control due to limited healthcare infrastructure. These findings highlight the urgent need for stringent antimicrobial stewardship practices, enhanced infection control, and tailored interventions in resource-limited settings. It is also to be emphasized that the main mechanism of carbapenem resistance in Kp organisms in Asia seems to be different from the West and is mainly mediated by metallo-beta-lactamases and Class D carbapenemases.
- 5 February 2025
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 71 (2)
Colistin-resistant Klebsiella pneumoniae sepsis in neonates and infants: an alarming crisis in an Indian NICU
Emergence of multidrug-resistant strain of Klebsiella pneumoniae has led to limited number of antimicrobial options for treatment. Even though outbreaks of colistin–carbapenem-resistant K. pneumoniae (CCRKp) are evolving, reported literature is scarce. This is a retrospective case series of three infants who acquired CCRKp sepsis during an outbreak in a Level III neonatal intensive care unit (NICU) of a tertiary care centre in Northern India. Data were retrieved from medical records of patients. Three babies developed new onset clinical worsening during an outbreak of sepsis. All had respiratory comorbidities and previous antibiotic exposure prior to isolation of CCRKp sepsis from blood. The organism was sensitive to combination of ceftazidime plus avibactam and tetracyclines in two infants; in one other newborn, no sensitive antibiotic was found. Two neonates deceased due to multiorgan dysfunction. An outbreak investigation revealed one common source of sterile water used in a humidifier. The outbreak was resolved by temporarily closing the NICU, segregating the infected infants and using corrective measures such as procuring a fresh batch of sterile water bottles, disinfecting the NICU, and reinforcing the use of antiseptic techniques. The emergence of CCRKp is alarming, particularly in low- and middle-income countries and tropical regions where such outbreaks are difficult to control due to limited healthcare infrastructure. These findings highlight the urgent need for stringent antimicrobial stewardship practices, enhanced infection control, and tailored interventions in resource-limited settings. It is also to be emphasized that the main mechanism of carbapenem resistance in Kp organisms in Asia seems to be different from the West and is mainly mediated by metallo-beta-lactamases and Class D carbapenemases.
- 11 November 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (11) , e260799
Barth syndrome: a rare cause of cardiomyopathy in neonates
Barth syndrome (BTHS) is one of the rare X linked recessive diseases that appear in infancy with a triad of myocardial and skeletal muscle diseases, neutropenia and growth retardation. The pathogenic variant of TAFAZZIN gene leads to BTHS, which encodes the TAFAZZIN protein of the inner membrane of the mitochondria, a phosphatidyltransferase involved in cardiolipin remodelling and functional maturation. We present a case of a neonate presenting with early-onset cardiomyopathy, neutropenia and failure to thrive with no family history of cardiac diseases. Echocardiography suggested a dilated left ventricle with non-compaction and a low ejection fraction. The baby was managed with diuretics and decongestive measures. Clinical exome sequencing detected a hemizygous novel splice site variant c.541+2 T>C in TAFAZZIN, confirming the diagnosis of BTHS.
- 11 November 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (11) , e260799
Barth syndrome: a rare cause of cardiomyopathy in neonates
Barth syndrome (BTHS) is one of the rare X linked recessive diseases that appear in infancy with a triad of myocardial and skeletal muscle diseases, neutropenia and growth retardation. The pathogenic variant of TAFAZZIN gene leads to BTHS, which encodes the TAFAZZIN protein of the inner membrane of the mitochondria, a phosphatidyltransferase involved in cardiolipin remodelling and functional maturation. We present a case of a neonate presenting with early-onset cardiomyopathy, neutropenia and failure to thrive with no family history of cardiac diseases. Echocardiography suggested a dilated left ventricle with non-compaction and a low ejection fraction. The baby was managed with diuretics and decongestive measures. Clinical exome sequencing detected a hemizygous novel splice site variant c.541+2 T>C in TAFAZZIN, confirming the diagnosis of BTHS.